Cathay Capital completed a 3.18 billion yuan series D financing round, with Shanghai Science and Technology Innovation Group leading the investment.

On June 10th, Casecade Pharmaceutical Technology Co., Ltd. officially announced the completion of a 318 million yuan Series D financing. This round of financing was led by Taiping Healthcare Fund and Shanghai Science and Technology Innovation Group under Shanghai Guotou, with participation from YkCapital, Zhaode Investment, LinkCo Fund, and many other professional investment institutions.